Wa. Devane et J. Axelrod, ENZYMATIC-SYNTHESIS OF ANANDAMIDE, AN ENDOGENOUS LIGAND FOR THE CANNABINOID RECEPTOR, BY BRAIN MEMBRANES, Proceedings of the National Academy of Sciences of the United Statesof America, 91(14), 1994, pp. 6698-6701
Anandamide, an endogenous eicosanoid derivative (arachidonoylethanolam
ide), binds to the cannabinoid receptor, a member of the G protein-cou
pled superfamily. It also inhibits both adenylate cyclase and N-type c
alcium channel opening. The enzymatic synthesis of anandamide in bovin
e brain tissue was examined by incubating brain membranes with [C-14]e
thanolamine and arachidonic acid. Following incubation and extraction
into toluene, a radioactive product was identified which had the same
R(f) value as authentic anandamide in several thin-layer chromatograph
ic systems. When structurally similar fatty acid substrates were compa
red, arachidonic acid exhibited the lowest EC(50) and the highest acti
vity for enzymatic formation of the corresponding ethanolamides. The c
oncentration-response curve of arachidonic acid exhibited a steep slop
e, and at higher concentrations arachidonate inhibited enzymatic activ
ity. When brain homogenates were separated into subcellular fractions
by sucrose density gradient centrifugation, anandamide synthase activi
ty was highest in fractions enriched in synaptic vesicles, myelin, and
microsomal and synaptosomal membranes. When several areas of brain we
re examined, anandamide synthase activity was found to be highest in t
he hippocampus, followed by the thalamus, cortex, and striatum, and lo
west in the cerebellum, pens, and medulla. The ability of brain tissue
to enzymatically synthesize anandamide and the existence of specific
receptors for this eicosanoid suggest the presence of anandamide-conta
ining (anandaergic) neurons.